US-Listed Company Announces Unexpected Altcoin Investment! Here Are the Details
Silo Pharma, a company specializing in biopharmaceutical and cryptocurrency treasury management, announced the acquisition of ResearchCoin (RSC) as part of its digital asset strategy.
According to its official statement, the company aims to capture long-term value from multiple blockchain opportunities with this move.
ResearchCoin (RSC) stands out as the native token of ResearchHub, the decentralized scientific research platform founded by Coinbase CEO Brian Armstrong in 2019.
The platform aims to reshape scientific collaboration with blockchain technology. Silo Pharma CEO Eric Weisblum said, “With our investment in RSC, we are joining the growing decentralized science (DeSci) movement while also providing diversification and potential value growth for our shareholders.”
“The ResearchCoin investment demonstrates our commitment to modernizing scientific collaboration and supporting blockchain-driven innovation at the core of biomedical discovery.” Following the development, the RSC price rose by around 4% in the last 24 hours. The token has a market capitalization of $60 million and is listed on Coinbase.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI-Powered Hybrid Staking Approach Connects Web2 and Web3, Enhancing Accessibility
- IntelliQuant's Lumint platform introduces a hybrid node staking model combining AI with blockchain to simplify operations for institutional and retail users. - The model uses account abstraction and gas fee sponsorship to lower entry barriers while integrating Web2/Web3 technologies for familiar user experiences. - An AI-powered investment platform with robo-advisory and crypto trend analysis is in development, supported by OKX partnership for global expansion. - The hybrid-incentive system aims to creat
XRP News Update: Institutional Dominance Drives CoinShares to Adjust Its Crypto Approach
- CoinShares abandoned U.S. XRP/Solana/LTC ETF plans due to a crowded market dominated by institutional giants like BlackRock and Fidelity. - The firm will pivot to high-margin thematic crypto products and active strategies, exiting leveraged Bitcoin futures ETF BTFX . - Institutional dominance in crypto ETFs now exceeds 90% of inflows, with BlackRock's IBIT controlling $70B+ in assets and 3% of Bitcoin's supply. - XRP ETFs saw $179.6M inflows this week, but CoinShares cited "low margins and slow growth" c
Ethereum Updates Today: Fed's QT Conclusion and FUSAKA Enhancement May Drive Ethereum's Upcoming Surge
- Ethereum tests $2,850 support as ETF inflows and FUSAKA upgrade boost institutional confidence. - FUSAKA upgrade introduces PeerDAS, boosting data capacity eightfold and cutting L2 fees by 90%. - Fed’s December QT end and rate cut expectations fuel liquidity and bullish sentiment. - Technical indicators show consolidation near $2,800–$3,080, with potential for $3,550 by mid-2026 if upgrades align with liquidity.
Crypto’s Harmful Culture Poses a Greater Risk to Growth Than Bear Markets, According to Hoskinson
Trending news
MoreCrypto prices
More
